Kamada
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- -
- Employees
- 378
- Market Cap
- $326M
- Introduction
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the drug products in Israel, which are manufactured by third parties. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.
Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency
Phase 2
Completed
- Conditions
- First Posted Date
- 2007-04-13
- Last Posted Date
- 2007-10-17
- Lead Sponsor
- Kamada, Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT00460096
- Locations
- 🇺🇸
National Jewish Medical and Research Center, Denver, Colorado, United States
🇺🇸University of Florida School of Medicine, Gainesville, Florida, United States
🇺🇸The University of Texas Health Center at Tyler, Tyler, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath